Recommended Topic Related To:

Viokase

"The U.S. Food and Drug Administration today approved Movantik (naloxegol), an oral treatment for opioid-induced constipation in adults with chronic non-cancer pain.

Opioids are a class of drugs that are used to treat and manage pain. A comm"...

Viokase

PATIENT INFORMATION

VIOKASE® (pancrelipase tablets, powder) should not be held in the mouth as the proteolytic action may cause irritation of the mucosa.

Avoid inhalation of the powder when administering VIOKASE® (pancrelipase tablets, powder) .

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Last reviewed on RxList: 12/9/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


GI Disorders

Get the latest treatment options.